4.7 Article

Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-kappa B pathway to promote metastasis

Journal

CELL DEATH & DISEASE
Volume 12, Issue 6, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-021-03823-4

Keywords

-

Categories

Funding

  1. CAMS Innovation Fund for Medical Sciences (CIFMS) [2016-I2M-1-001]
  2. Beijing Science and Technology Program [D17110002617004]
  3. China Postdoctoral Science Foundation [2018M641856]
  4. Heilongjiang Postdoctoral Fund [LBH-Z18200]
  5. Postgraduate Research & Practice Innovation Program of Harbin Medical University [YJSKYCX2019-51HYD]

Ask authors/readers for more resources

Research demonstrates that the expression of FAP in colorectal cancer cells is associated with the NF-kappa B signaling pathway, and upregulation of FAP contributes to promoting tumor cell migration and invasion. Binding to ENO1 can activate the NF-kappa B signaling pathway, and high levels of both FAP and ENO1 indicate a poor prognosis in colorectal cancer patients.
Fibroblast activation protein alpha (FAP) is a marker of cancer-associated fibroblast, which is also expressed in cancer epithelial cells. However, the role of FAP in colorectal cancer (CRC) cells remains to be elucidated. Here we investigate the expression pattern of FAP in CRC tissues and cells to prove that FAP is upregulated in CRC cells. Loss- of and gain-of-function assays identified FAP promotes migration and invasion instead of an effect on cell proliferation. Microarray assays are adopted to identify the different expressed genes after FAP knockdown and gene set enrichment analysis (GSEA) is used to exploit the involved signaling pathway. Our works reveal FAP exerts a function dependent on NF-kappa B signaling pathway and FAP expression is associated with NF-kappa B signaling pathway in clinical samples. Our work shows FAP is secreted by CRC cells and soluble FAP could promote metastasis. To investigate the mechanism of FAP influencing the NF-kappa B signaling pathway, LC/MS is performed to identify the proteins interacting with FAP. We find that FAP binds to ENO1 and activates NF-kappa B signaling pathway dependent on ENO1. Blocking ENO1 could partially reverse the pro-metastatic effect mediated by FAP. We also provide evidences that both FAP and ENO1 are associated with CRC stages, and high levels of FAP and ENO1 predict a poor survival in CRC patients. In summary, our work could provide a novel mechanism of FAP in CRC cells and a potential strategy for treatment of metastatic CRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available